The low negative likelihood ratio in this analysis suggests that PSMA PET-CT may be used to rule out disease in patients with a clinical suspicion of PCa, potentially avoiding unnecessary biopsies [33]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.